Venbio Global Strategic Gp, Ltd. - Net Worth and Insider Trading

Venbio Global Strategic Gp, Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Venbio Global Strategic Gp, Ltd. owns 3 companies in total, including Metacrine Inc (MTCR) , ALX Oncology Holdings Inc (ALXO) , and Precision BioSciences Inc (DTIL) .

Click here to see the complete history of Venbio Global Strategic Gp, Ltd.’s form 4 insider trades.

Insider Ownership Summary of Venbio Global Strategic Gp, Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
MTCR	Metacrine Inc	2020-09-18	10 percent owner & other: See Remarks
ALXO	ALX Oncology Holdings Inc	2020-07-16	10 percent owner & other: See Remarks
DTIL	Precision BioSciences Inc	2019-03-27	10 percent owner

Venbio Global Strategic Gp, Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Venbio Global Strategic Gp, Ltd. Ownership Network

Ownership Network List of Venbio Global Strategic Gp, Ltd.

No Data

Ownership Network Relation of Venbio Global Strategic Gp, Ltd.

Venbio Global Strategic Gp, Ltd. Owned Company Details

What does Metacrine Inc do?

Who are the key executives at Metacrine Inc?

Venbio Global Strategic Gp, Ltd. is the 10 percent owner & other: See Remarks of Metacrine Inc. Other key executives at Metacrine Inc include Chief Business Officer Michael York , director & President & CEO Preston Klassen , and 10 percent owner Braden Michael Leonard .

Metacrine Inc (MTCR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metacrine Inc (MTCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Metacrine Inc Insider Transactions

No Available Data

What does ALX Oncology Holdings Inc do?

Who are the key executives at ALX Oncology Holdings Inc?

Venbio Global Strategic Gp, Ltd. is the 10 percent owner & other: See Remarks of ALX Oncology Holdings Inc. Other key executives at ALX Oncology Holdings Inc include VP & Finance and CAO Shelly Pinto , Chief Medical Officer Sophia Randolph , and director & President and CEO Jaume Pons .

ALX Oncology Holdings Inc (ALXO) Insider Trades Summary

Over the past 18 months, Venbio Global Strategic Gp, Ltd. made no insider transaction in ALX Oncology Holdings Inc (ALXO). Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 145,903 shares made by Jaume Pons , a net sale of 14,288 shares made by Shelly Pinto , and a net sale of 18,243 shares made by Sophia Randolph .

In summary, during the past 3 months, insiders sold 3,866 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 0 shares, with a net sale of 3,866 shares. During the past 18 months, 179,321 shares of ALX Oncology Holdings Inc (ALXO) were sold and 28,400 shares were bought by its insiders, resulting in a net sale of 150,921 shares.

ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ALX Oncology Holdings Inc Insider Transactions

No Available Data

What does Precision BioSciences Inc do?

Who are the key executives at Precision BioSciences Inc?

Venbio Global Strategic Gp, Ltd. is the 10 percent owner of Precision BioSciences Inc. Other key executives at Precision BioSciences Inc include director & President and CEO Michael Amoroso , General Counsel Dario Scimeca , and 10 percent owner J. Jefferson Smith .

Precision BioSciences Inc (DTIL) Insider Trades Summary

Over the past 18 months, Venbio Global Strategic Gp, Ltd. made no insider transaction in Precision BioSciences Inc (DTIL). Other recent insider transactions involving Precision BioSciences Inc (DTIL) include a net sale of 51,624 shares made by Dario Scimeca , a net sale of 266,953 shares made by Michael Amoroso , and a net sale of 28,204 shares made by J. Jefferson Smith .

In summary, during the past 3 months, insiders sold 3,600 shares of Precision BioSciences Inc (DTIL) in total and bought 0 shares, with a net sale of 3,600 shares. During the past 18 months, 18,310 shares of Precision BioSciences Inc (DTIL) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 15,310 shares.

Precision BioSciences Inc (DTIL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Precision BioSciences Inc Insider Transactions

No Available Data

Venbio Global Strategic Gp, Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Venbio Global Strategic Gp, Ltd.. You might contact Venbio Global Strategic Gp, Ltd. via mailing address: 1700 Owens Street, Suite 595, San Francisco Ca 94158.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.